celastrol has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, X; Gan, K; Tan, W; Wang, F; Xu, L; Zhang, M; Zhang, Q | 1 |
| Idris, AI; Krishnan, M; Landao-Bassonga, E; Mollat, P; Ralston, SH; Simic, P; Vukicevic, S | 1 |
2 other study(ies) available for celastrol and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Celastrol attenuates bone erosion in collagen-Induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7.
Topics: Acid Phosphatase; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Resorption; Cell Differentiation; Cell Line; Gene Expression Regulation; Humans; Isoenzymes; Joints; Medicine, Chinese Traditional; Mice; Mice, Inbred Strains; Osteoclasts; Pentacyclic Triterpenes; RANK Ligand; Tartrate-Resistant Acid Phosphatase; Transcriptional Activation; Tripterygium; Triterpenes | 2015 |
Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Cell Differentiation; Cell Survival; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Female; Humans; I-kappa B Kinase; Imidazoles; Inhibitory Concentration 50; Mice; Osteoclasts; Ovariectomy; Pentacyclic Triterpenes; Quinoxalines; Sesquiterpenes; Signal Transduction; Triterpenes | 2010 |